BioMe Oxford
Generated by Meeveem AI
"Developing pill-sized devices for minimally invasive gut microbiome sampling"
Woodstock
•1 - 10 Employees
•Medical Devices
About BioMe Oxford
BioMe Oxford develops BioCapture, a pill-sized medical device for targeted and minimally invasive sampling of the human gut microbiome. The device addresses limitations in current diagnostic methods, which are often expensive, invasive, or inaccurate. BioCapture enables accurate sampling from any part of the intestines, suitable for research and clinical use. The gut microbiome has been linked to conditions including inflammatory bowel disease, diabetes, obesity, and cardiovascular diseases. By enabling cost-effective and accessible microbiome sampling, BioMe Oxford improves understanding of how microbial signatures relate to disease, supporting better diagnosis, monitoring, and therapeutic strategies.
4
Team Members
2015
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where gut microbiome insights are accessible to everyone, transforming disease diagnosis, monitoring, and prevention through affordable and minimally invasive sampling technology.
Our Mission
BioMe Oxford enables population-wide microbiome studies through minimally invasive and cost-effective sampling technology, informing new therapeutic strategies and improving disease diagnosis and management.